The gastrointestinal epithelium is an example of barrier tissue, which controls the passage of molecules between different compartments of the body. The epithelium consists of elongated columnar cells joined together by complexes of proteins that provide a physical barrier1 against pathogens and toxins, while allowing the passage of water and nutrients required to sustain the body. This selectivity is due to the polarization of the epithelial cells, which creates two different membrane domains: the apical side of the cells exposed to the lumen and the basal side of the cells anchored on the underlying tissues2,3. Tight junctions (TJ) are complexes of proteins present at the apical portion of epithelial cells and are part of a larger complex known as the apical junction4. Ion flow across the barrier tissue may either go via the transcellular (through the cell) or via a paracellular (between two adjacent cells) pathway. The sum of the transport through both pathways is known as the transepithelial resistance. The apical junction is responsible for the regulation of ions and molecules passing across the barrier5,6 via a specific opening and closing function. A dysfunction or disruption of these protein complexes is often related to disease7-11. In addition, many enteric pathogens/toxins are known to specifically target this complex, thereby entering the body and leading to diarrhea, most likely as a consequence of massive dysregulation of ion/water flow across the barrier12-14. Barrier tissue may also be modified by changing the extracellular microenvironment. Cadherin is a critical protein for cell-cell adhesion, and is involved in the formation of the apical junction. Calcium is required for the correct structural conformation of Cadherin, and a decrease in extracellular calcium has been shown to result in the destruction of the cell-cell junction and a subsequent opening of the paracellular pathway between the cells15. In this study, EGTA (Ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetra acetic acid), a specific calcium chelator, was used to induce a breach in barrier tissue, as it has been shown to have a rapid and drastic effect on paracellular ion flow16,17. This calcium chelator was used on a confluent and differentiated monolayer of the Caco-2 cell-line. Cultured in cell culture inserts, this cell line is known to develop the characteristics of the gastrointestinal tract and is widely used by the pharmaceutical industry to test the absorption of drugs18,19.
Methods to monitor barrier tissue integrity are plentiful. These methods are often optical, relying on immunofluorescence staining of particular proteins known to be at the apical junction20, or relying on the quantification of a fluorescent tracer molecule that is normally impermeable to the barrier tissue21,22. However, label-free methods (i.e. without a fluorophore/chromophore) are preferable as the use of a label can incur artifacts, and often increases cost and assay time. Electrical, label-free monitoring of barrier tissue has recently emerged as a dynamic monitoring method23. For example recent technological advances in electrical impedance spectroscopy have allowed the development of a commercially available scanning apparatus24,25 that can measure transepithelial resistance (TER), a measurement of the ion conductance across the cell layer.
Organic electronics has created a unique opportunity to interface the world of electronics and biology26,27 28,29 by using conducting polymers that can conduct both electronic and ionic carriers. A new technique to detect breaches in barrier tissue using the OECT30-32 was recently introduced. This device was validated against existing techniques used to assess barrier tissue integrity, including immunofluorescence, permeability assays using Lucifer yellow, and impedance spectroscopy using the Cellzscope. In the case of all toxic compounds tested, the OECT was found to operate with equal or better sensitivity, and with increased temporal resolution, compared to the above techniques. In this device, PEDOT:PSS, a conducting polymer that has been shown to be stable and biocompatible33,34, is used as the active material in the transistor channel. The OECT is composed of drain and source electrodes on either side of a conducting polymer channel. This is then placed in contact with an electrolyte, which forms an integral part of the device. A gate electrode is immersed in the electrolyte (Figure 1), and when a positive gate voltage is applied at the gate, cations from the electrolyte are forced into the channel, thus dedoping the conducting polymer and resulting in a change in the source-drain current. The device is thus extremely sensitive to minute changes in ionic flux due to amplification by the transistor. A cell layer grown on a cell culture insert was placed between the gate electrode and the conducting polymer channel. The presence of an intact cell layer acts as barrier for the cations entering into the conducting polymer, therefore, in the presence of an intact monolayer, the drain current decreases (Figure 2: transition from region a to b). In the presence of a toxic compound, the barrier tissue will progressively lose its integrity, letting the cations enter into the polymer film and increasing the drain current (Figure 2: region c). With this technique, the breach in barrier tissue is seen by the modulation of the drain current, corresponding to the modulation of the flux across the monolayer. This device is able to measure minute variations in ionic flux with unprecedented temporal resolution and sensitivity in real time. This technology will be of interest in the domain of toxicology for drug testing, disease diagnostics or basic research as the barrier model can be easily adapted. This method will also help to reduce animal experimentation, as it allows the validation of in vitro models to replace in vivo testing.